Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer starts first US "virtual" clinical study, under pilot FDA program using Internet
Yahoo/AP
Tuesday, June 7, 2011 - 6:16pm
tags:
clinical studies, Pfizer, FDA, Detrol, overactive bladder
APP launches generic version of Femara, drug linked to lower breast cancer risk in new study
Yahoo/AP
Tuesday, June 7, 2011 - 6:15pm
tags:
APP, Femara, breast cancer, generics, Novartis
Pfizer May Seek $1 Billion in Yearly Cost Cuts, WSJ Says
Bloomberg
Tuesday, June 7, 2011 - 6:14pm
tags:
Pfizer
FDA allows Actavis to market generic insomnia drug
Pharmaceutical Business Review
Tuesday, June 7, 2011 - 10:08am
tags:
FDA, Actavis, Ambien CR, insomnia, generics
Sanofi preps for new pivotal trial of a blockbuster hopeful
Fierce Biotech
Tuesday, June 7, 2011 - 10:01am
tags:
Sanofi, iniparib, breast cancer
Remark Haunts Drug Company in Overtime Pay Suit
BNET Pharma
Tuesday, June 7, 2011 - 9:58am
tags:
Endo, overtime lawsuits, drug reps
Biogen says European Union regulators approved once-a-week injection pen for MS
Yahoo/AP
Tuesday, June 7, 2011 - 9:54am
tags:
Biogen Idec, Europe, MS, multiple sclerosis, Avonex pen
Novo Nordisk: Convenient Diabetes Care Could Drive Growth
Seeking Alpha
Tuesday, June 7, 2011 - 9:52am
tags:
diabetes, Novo Nordisk
Analyst says Aeterna Zentaris shares could double on cancer drug development and approval
Yahoo/AP
Tuesday, June 7, 2011 - 9:51am
tags:
Aeterna Zentaris, perifosine
Roche, Merck to Develop Tests for Merck’ Cancer Therapies
Bloomberg
Tuesday, June 7, 2011 - 9:51am
tags:
Roche, Merck, cancer
Glaxo, Crucell, PATH Malaria in Pact to Develop Malaria Vaccine
Bloomberg
Tuesday, June 7, 2011 - 9:50am
tags:
GSK, Crucell, vaccines, malaria
AstraZeneca Pays $250K For Sex Discrimination
Pharmalot
Monday, June 6, 2011 - 9:35pm
tags:
gender discrimination, AstraZeneca
Gen-Probe Shares Tumble on Report Novartis May Not Bid
Bloomberg
Monday, June 6, 2011 - 9:34pm
tags:
Gen-Probe, Novartis, M&A
Corcept Therapeutics details Corlux study results
Yahoo/AP
Monday, June 6, 2011 - 9:33pm
tags:
Corcept Therapeutics, Corlux, Cushing's syndrome
Repligen Earnings Preview
Motley Fool
Monday, June 6, 2011 - 9:32pm
tags:
earnings, Repligen
ASCO '11: Exelixis Updates Prostate Cancer Data
TheStreet.com
Monday, June 6, 2011 - 9:28pm
tags:
Exelixis, prostate cancer, ASCO, cabozantinib
Weekend at ASCO: Drugs for Skin, Lung, Ovarian Cancer
WSJ Online
Monday, June 6, 2011 - 9:27pm
tags:
ASCO, melanoma, ovarian cancer, lung cancer, Pfizer, crizotinib, vemurafenib, JNJ, prostate cancer, Roche, Avastin, Zytiga
Algeta shares spike on promising prostate cancer drug data
Fierce Biotech
Monday, June 6, 2011 - 12:34pm
tags:
Algeta, prostate cancer, Apharadin
With promising Ph3 data in hand, Incyte files for myelofibrosis drug OK
Fierce Biotech
Monday, June 6, 2011 - 12:31pm
tags:
Incyte, myelofibrosis, ruxolitinib
Novartis Likely Buyer for Gen-Probe
WSJ Online
Monday, June 6, 2011 - 12:29pm
tags:
Gen-Probe, M&A, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.